Eli Lilly (LLY) stock is in focus after the company reported better-than-expected results and issued a strong outlook. Bristol-Myers Squibb (BMY) shares are under pressure after the company ...

The fourth-quarter earnings season for the drug and biotech sector will be in full swing this week with many large drugmakers like — Merck, Pfizer, Eli Lilly and Co., Amgen and Bristol Myers ...

Per the Zacks classification, the pharma/biotech industry falls under the broader Medical sector, comprising pharma/biotech and generic companies, and medical device companies. Per the Earnings ...

Shares rise nearly 5% after upbeat forecast Drugmaker suggests demand for Zepbound and Mounjaro remains strong Lilly forecast earnings of $22.50 to $24.00 per share on an adjusted basis this year ...

But Aust services, in South Gloucestershire, has had a special place in the culture of Bristol and the West Country, ever since it served its first sausage and chips and heard its first gasped ...

Eli Lilly (LLY) stock is higher Thursday after the pharmaceutical company beat profit expectations and matched revenue forecasts for its fourth quarter and issued a better-than-expected outlook ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Now, J&J is among four drugmakers suing the government for blocking their 340B rebate proposals, joining Eli Lilly, Bristol Myers Squibb and Sanofi. The dispute adds to an ongoing battle over the ...

Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and Acumen Pharmaceuticals. Halozyme also develops, manufactures and commercializes, for itself or with partners ...